A single arm phase II trial of gemcitabine (G) and irinotecan (I) in metastatic breast cancer: Can localization of topoisomerase I (topo I) predict response to topo I inhibitors?

被引:0
作者
Moulder, S. L.
Valkov, N.
Minton, S.
Munster, P.
Gump, J.
Lacevic, M.
Rocha-Lima, C.
Horton, J.
Lush, R.
Sullivan, D.
机构
[1] H Lee Moffitt Canc Ctr, Tampa, FL USA
[2] Univ Miami, Sylvester Canc Ctr, Miami, FL 33152 USA
[3] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:43S / 43S
页数:1
相关论文
empty
未找到相关数据